Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together
RESEARCH ARTICLE (Open Access)

Respiratory virus surveillance in Australia: past, present and future

Allen C. Cheng A B C *
+ Author Affiliations
- Author Affiliations

A Monash Infectious Diseases, Monash Health, 246 Clayton Road, Clayton, Vic. 3168, Australia.

B School of Clinical Sciences, Monash University, Monash Medical Centre, Clayton, Vic., Australia.

C School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic. 3004, Australia.




Allen Cheng is an infectious diseases physician, epidemiologist and biostatistician. He is an investigator for the FluCAN surveillance system, and is a member of the National Influenza Surveillance Committee, as well as several other technical advisory committees.

* Correspondence to: allen.cheng@monash.edu.au

Microbiology Australia https://doi.org/10.1071/MA24056
Submitted: 27 August 2024  Accepted: 8 October 2024  Published: 28 October 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of the ASM. This is an open access article distributed under the Creative Commons Attribution 4.0 International License (CC BY).

Abstract

Surveillance for respiratory viruses has developed from being solely focused on influenza notification to a more sophisticated system that allows for a more comprehensive picture of the burden, severity and impact of several respiratory viruses. Although all surveillance is associated with some degree of bias, when combined these provide useful information on the respiratory virus activity. However, further improvements are possible using new sources of surveillance, such as linked administrative databases, and taking a broader view of surveillance that provides information for forecasting and on public health control measures.

Keywords: communicable diseases control, COVID-19, epidemiology, immunisation programs, Influenza, public health surveillance, respiratory viruses.

Biographies

MA24056_B1.gif

Allen Cheng is an infectious diseases physician, epidemiologist and biostatistician. He is an investigator for the FluCAN surveillance system, and is a member of the National Influenza Surveillance Committee, as well as several other technical advisory committees.

References

Halliday L et al. (1999) Annual report of the National Influenza Surveillance Scheme, 1998. Commun Dis Intell 23, 185-92.
| Google Scholar | PubMed |

Kelly PM et al. (2011) FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals. Med J Aust 194, 169-74.
| Crossref | Google Scholar | PubMed |

Carlson SJ et al. (2023) FluTracking: weekly online community-based surveillance of influenza-like illness in Australia, 2019 Annual Report. Commun Dis Intell. 47 1-20.
| Crossref | Google Scholar | PubMed |

Moberley S et al. (2019) FluTracking: weekly online community-based surveillance of influenza-like illness in Australia, 2017 Annual Report. Commun Dis Intell 43 1-16.
| Crossref | Google Scholar | PubMed |

Li-Kim-Moy J et al. (2016) Australian vaccine preventable disease epidemiological review series: influenza 2006 to 2015. Commun Dis Intell Q Rep 40, E482-E95.
| Google Scholar | PubMed |

Bernardo CO et al. (2020) Influenza-like illness in Australia: a comparison of general practice surveillance system with electronic medical records. Influenza Other Respir Viruses 14, 605-9.
| Crossref | Google Scholar | PubMed |

Clothier HJ et al. (2005) An evaluation of the Australian Sentinel Practice Research Network (ASPREN) surveillance for influenza-like illness. Commun Dis Intell Q Rep 29, 231-47.
| Google Scholar | PubMed |

Cheng AC et al. (2015) Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Commun Dis Intell Q Rep 39, E355-60.
| Google Scholar | PubMed |

Burrell AJC et al. (2021) Comparison of baseline characteristics, treatment and celinical outcomes of critically ill COVID-19 patients admitted in the first and second waves in Australia. Crit Care Resusc 23, 308-19.
| Crossref | Google Scholar | PubMed |

10  Ziegler T et al. (2022) Global influenza surveillance and response system: 70 years of responding to the expected and preparing for the unexpected. Lancet 400, 981-2.
| Crossref | Google Scholar | PubMed |

11  Hoang T et al. (2022) AusTrakka: fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic. Nat Commun 13, 865.
| Crossref | Google Scholar | PubMed |

12  Merrett JE et al. (2024) Highly sensitive wastewater surveillance of SARS-CoV-2 variants by targeted next-generation amplicon sequencing provides early warning of incursion in Victoria, Australia. Appl Environ Microbiol 90, e0149723.
| Crossref | Google Scholar | PubMed |

13  Butler D (2013) When Google got flu wrong. Nature 494, 155-6.
| Crossref | Google Scholar | PubMed |

14  Mott JA et al. (2023) Facing the future of respiratory virus surveillance: “the mosaic surveillance framework”. Influenza Other Respir Viruses 17, e13122.
| Crossref | Google Scholar | PubMed |

15  Australian Institute for Health and Welfare (2011) 2009 Adult Vaccination Survey: summary results. Catalogue number PHE 135. AIHW, Canberra, ACT, Australia. https://www.aihw.gov.au/reports/primary-health-care/2009-adult-vaccination-survey-summary-results/summary

16  Sullivan SG et al. (2016) Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness. Am J Epidemiol 184, 345-53.
| Crossref | Google Scholar | PubMed |

17  Cheng AC et al. (2013) Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010–11 seasons: a test-negative observational study. PLoS ONE 8, 68760.
| Crossref | Google Scholar | PubMed |

18  Biddle N et al. (2022) Socioeconomic determinants of vaccine uptake – July 2021 to January 2022. ANU COVID-19 Vaccine Series. Commonwealth of Australia, Canberra, ACT, Australia. https://www.health.gov.au/resources/publications/socioeconomic-determinants-of-vaccine-uptake-july-2021-to-january-2022?language=en

19  Liu B et al. (2023) Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection. Vaccine 41, 5587-91.
| Crossref | Google Scholar | PubMed |

20  Brookmeyer R, Morrison DE (2022) Estimating vaccine effectiveness by linking population-based health registries: some sources of bias. Am J Epidemiol 191, 1975-80.
| Crossref | Google Scholar | PubMed |

21  Shearer FM et al. (2024) Opportunities to strengthen respiratory virus surveillance systems in Australia: lessons learned from the COVID-19 response. Commun Dis Intell 48, 1-16.
| Crossref | Google Scholar | PubMed |